On March 12, 2026, OnKure Therapeutics, Inc. announced its financial results for Q4 and the full year ended December 31, 2025, highlighting a net loss of $13.5 million. The company reported approximately $59 million in cash and cash equivalents.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.